Methylation of NEUROG1 in Serum Is a Sensitive Marker for the Detection of Early Colorectal Cancer
暂无分享,去创建一个
Alexander Crispin | Rolf Lamerz | Petra Stieber | Jens Neumann | R. Lamerz | A. Crispin | F. Kolligs | A. Herbst | J. Neumann | A. Jung | P. Stieber | Andreas Jung | Andrea Ofner | Frank T Kolligs | A. Philipp | Andreas Herbst | Konstanze Rahmig | Alexander Philipp | Andrea Ofner | Konstanze Rahmig
[1] T. Seufferlein,et al. S3-Leitlinie „Kolorektales Karzinom” – Aktualisierung 2008 , 2008, Zeitschrift fur Gastroenterologie.
[2] B. Shapiro,et al. Free DNA in the serum of cancer patients and the effect of therapy. , 1977, Cancer research.
[3] P. Laird,et al. Adenocarcinoma Epigenetic Patterns in the Progression of Esophageal Updated Version , 2001 .
[4] Bela Molnar,et al. Aristaless-like homeobox-4 gene methylation is a potential marker for colorectal adenocarcinomas. , 2006, Gastroenterology.
[5] L. Joseph Melton,et al. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy , 2002 .
[6] M. Ziegler,et al. Attitude to Secondary Prevention and Concerns about Colonoscopy Are Independent Predictors of Acceptance of Screening Colonoscopy , 2010, Digestion.
[7] A. Zauber,et al. Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup. , 1993 .
[8] J. Herman,et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. , 2009, Cancer research.
[9] G. Friedman,et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. , 1992, The New England journal of medicine.
[10] Christian Pilarsky,et al. Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. , 2009, Clinical chemistry.
[11] D. Ransohoff,et al. Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population. , 2004, The New England journal of medicine.
[12] Charles J. Kahi,et al. Screening, surveillance, and primary prevention for colorectal cancer: a review of the recent literature. , 2008, Gastroenterology.
[13] P. Maisonneuve,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.
[14] P. Laird,et al. MethyLight: a high-throughput assay to measure DNA methylation. , 2000, Nucleic acids research.
[15] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[16] M. Guo,et al. Epigenetic changes in colorectal cancer , 2013, Chinese journal of cancer.
[17] J. Herman,et al. Methylation of TFPI 2 in Stool DNA : A Potential Novel Biomarker for the Detection of Colorectal Cancer , 2009 .
[18] Valeri Vasioukhin,et al. Point mutations of the N‐ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia , 1994, British journal of haematology.
[19] M. Toyota,et al. Epigenetic changes in solid and hematopoietic tumors. , 2005, Seminars in oncology.
[20] V A Memoli,et al. Soluble normal and mutated DNA sequences from single-copy genes in human blood. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[21] Daiya Takai,et al. Comprehensive analysis of CpG islands in human chromosomes 21 and 22 , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[22] Bela Molnar,et al. DNA methylation biomarkers for blood-based colorectal cancer screening. , 2008, Clinical chemistry.
[23] M. Widschwendter,et al. Methylated DNA as a possible screening marker for neoplastic disease in several body fluids , 2003, Expert review of molecular diagnostics.
[24] A. Schatzkin,et al. Colonoscopic screening of average-risk women for colorectal neoplasia. , 2005, The New England journal of medicine.
[25] P. Laird,et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer , 2006, Nature Genetics.
[26] S. Markowitz,et al. Improved fecal DNA test for colorectal cancer screening. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[27] J. Herman,et al. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. , 2001, Human molecular genetics.
[28] R. Lamerz,et al. Analysis of promoter methylation in stool: a novel method for the detection of colorectal cancer. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[29] Peter A. Jones,et al. The Epigenomics of Cancer , 2007, Cell.
[30] D. Sargent,et al. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia , 2008, Annals of Internal Medicine.
[31] L. Melton,et al. A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy , 2002, American Journal of Gastroenterology.
[32] Hermann Brenner,et al. Blood Markers for Early Detection of Colorectal Cancer: A Systematic Review , 2007, Cancer Epidemiology Biomarkers & Prevention.
[33] Douglas K Rex,et al. Corrigendum: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008 , 2009, The American Journal of Gastroenterology.
[34] T. Morikawa,et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. , 2005, Gastroenterology.
[35] R. Lamerz,et al. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence , 2009, European journal of gastroenterology & hepatology.
[36] Christian B. Woods,et al. Analysis of repetitive element DNA methylation by MethyLight , 2005, Nucleic acids research.
[37] Perry J Pickhardt,et al. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.
[38] B. Levin,et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.
[39] S. Goodman,et al. Sensitive digital quantification of DNA methylation in clinical samples , 2009, Nature Biotechnology.
[40] R. Ward,et al. Colorectal cancer: a model for epigenetic tumorigenesis , 2006, Gut.
[41] R. Lamerz,et al. Methylation of Serum DNA Is an Independent Prognostic Marker in Colorectal Cancer , 2006, Clinical Cancer Research.
[42] U. Lindforss,et al. Allelic loss is heterogeneous throughout the tumor in colorectal carcinoma , 2000, Cancer.